Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla informed in a tweet on Friday. Serum Institute, which produces AstraZeneca's Covid-19 vaccine under the brand name Covishield, has supplied more than 1.25 billion doses of the vaccine in India.
from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3EBiFJS
Post Top Ad
Responsive Ads Here
Friday, December 31, 2021
Home
India
India News | Latest News Headlines & Live Updates from India - Times of India
Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala
Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala
Tags
# India
# India News | Latest News Headlines & Live Updates from India - Times of India
Share This
About Unknown
India News | Latest News Headlines & Live Updates from India - Times of India
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
Author Details
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
No comments:
Post a Comment